Novo Nordisk A/S (NVO) Financials

NVO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 559.2 billion 54.6 billion
Dec. 31, 2025 542.9 billion 54.8 billion
Sept. 30, 2025 512.3 billion 53.8 billion
June 30, 2025 482.2 billion 49.6 billion

NVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 12.0 billion ?
Dec. 31, 2025 -36.2 billion ?
Sept. 30, 2025 30.7 billion ?
June 30, 2025 24.5 billion ?

NVO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 48.6 billion
Dec. 31, 2025 26.9 billion
Sept. 30, 2025 20.0 billion
June 30, 2025 26.5 billion

NVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 21.6 billion 18.3 billion -
Dec. 31, 2025 27.0 billion 17.3 billion 8.6 billion
Sept. 30, 2025 32.6 billion 14.0 billion -
June 30, 2025 18.9 billion 13.8 billion -

NVO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.4 billion
Dec. 31, 2025 4.4 billion
Sept. 30, 2025 4.4 billion
June 30, 2025 4.4 billion

NVO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.8 billion 1.6 billion 2.0 billion 12.1 billion
Dec. 31, 2025 6.9 billion 2.3 billion 2.7 billion 15.9 billion
Sept. 30, 2025 2.4 billion 2.4 billion 2.8 billion 16.0 billion
June 30, 2025 2.6 billion 1.8 billion 3.0 billion 17.5 billion

NVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 14.9 billion 13.6 billion
Dec. 31, 2025 12.4 billion 15.1 billion
Sept. 30, 2025 11.8 billion 17.9 billion
June 30, 2025 12.1 billion 12.8 billion

NVO

Price: $42.96

52 week price:
35.12
81.44

Dividend Yield: 4.28%

5-year range yield:
0.74%
5.17%

Forward Dividend Yield: 5.94%

Payout Ratio: 24.32%

Payout Ratio Range:
0.01%
449.50%

Dividend Per Share: 2.55 USD

Earnings Per Share: 4.30 USD

P/E Ratio: 10.79

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Denmark

Volume: 1.1 million

Ebitda: 1.9 billion

Market Capitalization: 186.9 billion

Average Dividend Frequency: 2

Years Paying Dividends: 45

DGR3: 29.57%

DGR5: 22.96%

DGR10: 20.32%

DGR20: 22.69%

Links: